DE
COMPANY

DeepIntent

DeepIntent is a healthcare-focused DSP and marketing cloud for pharmaceutical advertising.

Analyst Perspective

DeepIntent is a private US healthcare advertising technology company focused on pharmaceutical marketing. Its core offering is a healthcare-specific demand-side platform used by pharma brands, healthcare marketers, and agencies to plan, activate, optimise, and measure programmatic campaigns across channels including CTV, display, audio, video, and DOOH. The company combines media buying with healthcare audience data, clean room capabilities, and outcome measurement linked to clinical and prescribing signals. The business generates revenue primarily from media spend flowing through its DSP, supplemented by software and data revenue from products such as Helix, Cortex, Outcomes, and workflow tools for audience building and orchestration. Its customers are business buyers rather than consumers, chiefly enterprise pharmaceutical companies, healthcare-focused agencies, media planners, and marketing operations teams that need HIPAA-conscious targeting, healthcare datasets, and campaign measurement aligned to pharmaceutical KPIs such as script lift.

Analyst Signal Briefing

Updated: 19 Aug 2026

DeepIntent is expanding its inventory marketplace through a partnership with Vistar Media, integrating premium digital out-of-home inventory for healthcare marketers. This development follows its majority-stake acquisition by Vitruvian Partners and the appointment of former Trade Desk executive Ian Colley as CMO. By leveraging its Helix AI agentic platform and new live-streaming TV tools, DeepIntent is capturing market share as pharmaceutical advertisers reallocate budgets towards specialised, privacy-forward ad tech. This strategic growth is supported by a continuous influx of senior talent from legacy firms, targeting the projected $26.2 billion healthcare digital advertising market.

Explorer Tier

Start exploring for free

Start with public company intelligence. Save companies, build your first watchlist, and unlock deeper strategic insights when you are ready.

Free
  • View public Company Profiles
  • Save/watch companies
  • Build your first Watchlist
  • Access additional market signals

Category Differentiation

DeepIntent is a healthcare advertising technology platform for pharmaceutical media buying and measurement, not a general consumer health app or a healthcare provider. It is also distinct from broad horizontal DSPs because its core differentiation is healthcare-specific data, compliance, and outcome measurement.

DeepIntent: About

DeepIntent operates a vertical AdTech platform model centred on healthcare and pharmaceutical advertising. It creates value by combining compliant healthcare data, audience creation, programmatic media buying, marketplace supply access, and measurement into an integrated platform stack. This allows enterprise advertisers and agencies to run campaigns in regulated healthcare contexts with more relevant targeting and more sector-specific attribution than generalist ad platforms typically provide.

How DeepIntent Works & Monetises

Business model analysis and core revenue streams

DeepIntent primarily monetises through a percentage take-rate or platform economics attached to programmatic media spend executed through its DSP. It also appears to generate SaaS-style revenue from access to its healthcare marketing cloud, clean room, analytics, measurement, and workflow tools, plus premium data and audience access. Commercial arrangements likely include enterprise contracts, platform access fees, minimum spend commitments, bundled data-and-media packages, and premium inventory marketplace fees.

Revenue Channels

Programmatic media spend through DSPPercentage take-rate on media spend
Healthcare marketing cloud and clean room accessSaaS / software subscription
Measurement and analytics productsSaaS / software subscription
Audience and data accessLicensing or packaged platform fees
Premium inventory marketplace accessMarketplace margin or packaged media fees

Side-by-Side Comparisons

Compare DeepIntent directly with top competitors

DeepIntent: Key Competitors & Alternatives

View full competitor landscape

Recent Signals (DeepIntent)

DeepIntentAug 18, 2026

DeepIntent Expands Inventory Marketplace with Vistar Media Partnership, Bringing Premium Digital Out-of-Home Inventory to Healthcare Marketers

DeepIntent Expands Inventory Marketplace with Vistar Media Partnership, Bringing Premium Digital Out-of-Home Inventory to Healthcare Marketers

Read original source
ExchangeWireAug 12, 2026

IAB TCF Vendor List and Consent Disclosures Published

The ExchangeWire digest and registry page (published in August 2026) provides a primarily machine-readable IAB Transparency & Consent Framework (TCF 980) vendor disclosure listing dozens-to-hundreds of adtech, martech, measurement and publisher vendors. For each company the registry records declared Purposes (Consent vs Legitimate Interest), Special Purposes/Features, data categories processed (device, identifier, interaction, etc.), tracking methods, per-vendor consent expiry and data retention periods — including specific retention examples for some vendors. The alphabetical roster names major providers such as Branch Metrics, 33Across, Adobe Advertising Cloud/Audience Manager, Amazon Ads, Google Advertising Products, Criteo, LiveRamp and PubMatic. Intended as a machine-readable transparency resource for publishers, CMP operators and privacy/compliance teams, the page shows explicit publication timestamps in August 2026 (2026-08-12, 2026-08-13, 2026-08-19 and 2026-08-20).

Read original source
https://martechseries.com/feed/Jul 8, 2026

CTG Names Stefanie DeSantis Chief Marketing Officer

CTG, a Cegeka Group company providing IT and business solutions across the U.S., appointed Stefanie DeSantis as its Chief Marketing Officer on July 8, 2026. DeSantis will lead CTG’s marketing organization, overseeing brand strategy, demand generation, client engagement, and go-to-market initiatives to accelerate revenue growth across priority industries. CTG CEO Tom Niehaus endorsed her strategic marketing leadership. DeSantis has more than 15 years of marketing leadership experience with prior roles including Senior Vice President of Marketing at Precision AQ and marketing leadership positions at DeepIntent, Aledade, and Florida Blue.

Read original source

DeepIntent: Frequently Asked Questions

What is DeepIntent?

DeepIntent is a healthcare-focused advertising technology company that provides a DSP, data tools, and measurement products for pharmaceutical marketing.

Who uses DeepIntent?

Its primary users are pharmaceutical brands, healthcare marketers, media agencies, programmatic teams, and pharma marketing operations teams.

How does DeepIntent make money?

It makes money mainly from media spend flowing through its DSP, alongside software, data, and analytics fees for its broader healthcare marketing platform.

Company Facts

Founded
2016
Headquarters
4 Bryant Park, 4th Floor New York, NY 10018
Core Segment
AdTech Vendor
Company Size
201–500
Official Link
deepintent.com